Mental health benefits of omega-3 fatty acids may be mediated by improvements in cerebral vascular function

Bioscience Hypotheses

Volumn 1, Issue 2, 2008, Pages 103-108

  Sinn, N ^a   Howe, P R C ^a  

^a UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

Author keywords

Blood brain barrier; Cerebral blood flow; Endothelium; Omega 3 fatty acids; Psychiatric illness

Indexed keywords

NEUROTRANSMITTER; OMEGA 3 FATTY ACID;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; BLOOD BRAIN BARRIER; BLOOD VESSEL PERMEABILITY; BRAIN BLOOD FLOW; BRAIN DEVELOPMENT; BRAIN FUNCTION; BRAIN OXYGEN CONSUMPTION; BRAIN PERFUSION; DIET SUPPLEMENTATION; DRUG MECHANISM; ENDOTHELIUM CELL; EVIDENCE BASED MEDICINE; GLUCOSE TRANSPORT; HUMAN; MENTAL DISEASE; MENTAL HEALTH; NEUROPATHOLOGY; NEUROTRANSMISSION; NONHUMAN; PATHOPHYSIOLOGY; SIGNAL TRANSDUCTION; VASODILATATION;

EID: 84950170726     PISSN: 17562392     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bihy.2008.02.003     Document Type: Article

References (56)

1. Crawford M.A., and Sinclair A.J. Nutritional influences in the evolution of mammalian brain. Lipids, malnutrition and the developing brain (1971), ASP/Elsevier, Excerpta Medica, Amsterdam/North-Holland
2. Sinclair A.J., and Crawford M.A. The accumulation of arachidonate and docosahexaenoate in the developing rat brain. J Neurochem 19 (1972) 1753-1758
3. Young G., and Conquer J. Omega-3 fatty acids and neuropsychiatric disorders. Reprod Nutr Dev 45 (2005) 1-28
4. Richardson A.J. Omega-3 fatty acids in ADHD and related neurodevelopmental disorders. Int Rev Psychiatry 18 6 (2006) 155-172
5. Assisi A., Banzi R., Buoinocore C., et al. Fish oil and mental health: the role of n-3 long-chain polyunsaturated fatty acids in cognitive development and neurological disorders. Int Clin Psychopharmacol 21 6 (2006) 319-336
6. Haag M. Essential fatty acids and the brain. Can J Psychiatry 48 3 (2003) 195-203
7. Horrobin D.F. The membrane phospholipid hypothesis as a biochemical basis for the neurodevelopmental concept of schizophrenia. Schizophr Res 30 (1998) 193-208
8. Horrobin D.F. The phospholipid concept of psychiatric disorders and its relationship to the neurodevelopmental concept of schizophrenia. In: Peet M., Glen I., and Horrobin D.F. (Eds). Phospholipid spectrum disorder in psychiatry (1999), Marius Press, Carnforth 3-20
9. Sinclair A.J., Begg D., Mathai M., and Weisinger R. Omega 3 fatty acids and the brain: review of studies in depression. Asia Pac J Clin Nutr 16 Suppl. 1 (2007) 391-397
10. Chalon S., Vancassel S., Zimmer L., Guilloteau D., and Durand G. Polyunsaturated fatty acids and cerebral function: focus on monoaminergic neurotransmission. Lipids 36 9 (2001) 937-944
11. Salem Jr. N., Litman B., Kim H.-Y., and Gawrisch K. Mechanisms of action of docosahexaenoic acid. Lipids 36 9 (2001) 945-959
12. Iadecola C. Neurovascular regulation in the normal brain and in Alzheimer's disease. Nat Rev Neurosci 5 (2004) 347-360
13. Buunk G., van der Hoeven J.G., and Meinders A.E. Cerebral blood flow after cardiac arrest. Neth J Med 57 (2000) 106-112
14. Benton D. Diet, cerebral energy metabolism, and psychological functioning. In: Lieberman H.R., Kanarek R.B., and Prasad C. (Eds). Nutritional neuroscience (2005), Taylor & Francis Group, Boca Raton 57-71
15. Bourre J.-M. Effects of nutrients (in food) on the structure and function of the nervous system: update on dietary requirements for brain, part 1: micronutrients. J Nutr Health Aging 10 5 (2006) 377-385
16. Benarroch E. Neurovascular unit dysfunction: a vascular component of Alzheimer disease?. Neurology 68 20 (2007) 1730-1732
17. Faraci F.M., and Heistad D.D. Regulation of the cerebral circulation: role of endothelium and potassium channels. Physiol Rev 78 1 (1998) 53-97
18. Brown A.A., and Hu F.B. Dietary modulation of endothelial function: implications for cardiovascular disease. Am J Clin Nutr 73 (2001) 673-686
19. White R.P., Vallanc P., and Markus H.S. Effect of inhibition of nitric oxide synthase on dynamic cerebral autoregulation in humans. Clin Sci (Lond) 99 6 (2000) 555-560
20. Abbott N.J., Rönnbäck L., and Hansson E. Astrocyte-endothelial interactions at the blood-brain barrier. Nat Rev Neurosci 7 (2006) 41-53
21. Faraci F.M. Reactive oxygen species: influence on cerebral vascular tone. J Appl Physiol 100 (2006) 739-743
22. Janigro D., West G.A., Nguyen T.S., and Winn H.R. Regulation of blood-brain barrier endothelial cells by nitric oxide. Circ Res 75 (1994) 528-538
23. Logan A. When the drugs don't work. Br J Gen Pract 55 517 (2005) 639
24. Kornstein S.G., and Schneider R.K. Clinical features of treatment-resistant depression. J Clin Psychiatry 62 Suppl. 16 (2001) 18-25
25. McDonagh M.S., and Peterson K. Drug class review on pharmacologic treatments for ADHD (2005), Oregon Health & Science University, Oregon p. 616
26. Sun Z.-W., Zhu Y.-X., Liu H.-Y., et al. Decreased cerebral blood flow velocity in apolipoprotein E epsilon4 allele carriers with mild cognitive impairment. Eur J Neurol 14 (2007) 150-155
27. Crawford J.G. Alzheimer's disease risk factors as related to cerebral blood flow. Med Hypotheses 46 4 (1996) 367-377
28. Crawford J.G. Alzheimer's disease risk factors as related to cerebral blood flow: additional evidence. Med Hypotheses 50 1 (1998) 25-36
29. Warkentin S., Ohlsson M., Wollmer P., Edenbrandt L., and Minthon L. Regional cerebral blood flow in Alzheimer's disease: classification and analysis of heterogeneity. Dement Geriatr Cogn Disord 17 (2004) 207-214
30. Bradley J.D.D., and Golden C.J. Biological contributions to the presentation and understanding of attention-deficit/hyperactivity disorder: a review. Clin Psychol Rev 21 6 (2001) 907-929
31. Yazici K.M., Kapucu O., Erbas B., Varoglu E., Gülec C., and Bekdik C. Assessment of changes in regional cerebral blood flow in patients with major depression using the 99mTc-HMPAO single photon emission tomography method. Eur J Nucl Med Mol Imaging 19 12 (1992) 1038-1043
32. Mori K., Teramoto K., Nagao M., Horiguchi J., and Yamawaki S. Regional cerebral blood flow in schizophrenia using stable xenon-enhanced computed tomography. Neuropsychobiol 39 (1999) 117-124
33. Liu Z., Tam W.-C.C., Xie Y., and Zhao J. The relationship between regional cerebral blood flow and the Wisconsin Card Sorting Test in negative schizophrenia. Psychiatry Clin Neurosci 56 (2002) 3-7
34. Selley M.L. Increased concentrations of homocysteine and asymmetric dimethylarginine and decreased concentrations of nitric oxide in the plasma of patients with Alzheimer's disease. Neurobiol Aging 24 7 (2003) 903
35. Freemantle E., Vandal M., Tremblay-Mercier J., et al. Omega-3 fatty acids, energy substrates, and brain function during aging. Prostaglandins Leukot Essent Fatty Acids 75 (2006) 213-220
36. Waldstein S.R., Rice S.C., Thayer J.F., Najjar S.S., Scuteri A., and Zonderman A.B. Pulse pressure and pulse wave velocity are related to cognitive decline in the Baltimore Longitudinal Study of Aging. [published online Nov 19, 2007]. Hypertension (2008) 10.1161/hypertensionaha.107.093674
37. Jefferson A.L., Poppas A., Paul R.H., and Cohen R.A. Systemic hypoperfusion is associated with executive dysfunction in geriatric cardiac patients. Neurobiol Aging 28 (2007) 477-483
38. Duschek S., Hadjamu M., and Schandry R. Enhancement of cerebral blood flow and cognitive performance following pharmacological blood pressure elevation in chronic hypotension. Psychophysiol 44 (2007) 145-153
39. Pratt L.A., Ford D.E., Crum R.M., Armenian H.K., Gallo J.J., and Eaton W.W. Depression, psychotropic medication, and risk of myocardial infarction. Circulation 94 (1996) 3123-3129
40. Frasure-Smith N., Lespérance F., and Julien P. Major depression is associated with lower omega-3 fatty acid levels in patients with recent acute coronary syndromes. Biol Psychiatry 55 (2004) 891-896
41. Abeywardena M.Y., and Head R.J. Longchain n-3 polyunsaturated fatty acids and blood vessel function. Cardiovasc Res 52 (2001) 361-371
42. De Caterina R.R., and Massaro M. Omega-3 fatty acids and the regulation of expression of endothelial pro-atherogenic and pro-inflammatory genes. J Membr Biol 206 2 (2005) 103-116
43. Hill A.M., Buckley J.D., Murphy K.J., and Howe P.R.C. Combining fish-oil supplements with regular aerobic exercise improves body composition and cardiovascular disease risk factors. Am J Clin Nutr 85 (2007) 1267-1274
44. Leeson C.P.M., Mann A., Kattenhorn M., Deanfield J.E., Lucas A., and Muller D.P.R. Relationship between circulating n-3 fatty acid concentrations and endothelial function in early adulthood. Eur Heart J 23 (2002) 216-222
45. Goodfellow J., Bellamy M.F., Ramsey M.W., Jones C.J., and Lewis M.J. Dietary supplementation with marine omega-3 fatty acids improve systemic large artery endothelial function in subjects with hypercholesterolemia. J Am Coll Cardiol 35 2 (2000) 265-270
46. Simopoulos A.P. Omega-3 fatty acids in health and disease and in growth and development. Am J Clin Nutr 54 (1991) 438-463
47. Gibson R.A. The effect of diets containing fish and fish oils on disease risk factors in humans. Aust N Z J Med 18 (1988) 713-722
48. Mori T.A., Watts G.F., Burke V., Hilme E., Puddey I.B., and Beilin L.J. Differential effects of eicosapentaenoic acid and docosahexaenoic acid on vascular reactivity of the forearm microcirculation in hyperlipidemic, overweight men. Circulation 102 (2000) 1264-1269
49. da Silva A.X., Lavialle F., Gendrot G., Guesnet P., Alessandri J.M., and Lavialle M. Glucose transport and utilization are altered in the brain of rats deficient in n-3 polyunsaturated fatty acids. J Neurochem 81 (2002) 1328-1337
50. Pifferi F., Roux F., Langelier B., et al. (n-3) polyunsaturated fatty acid deficiency reduces the expression of both isoforms of the brain glucose transporter GLUT1 in rats. J Nutr 135 (2005) 2241-2246
51. Farkas E., de Wilde M.C., Kiliaan A.J., and Luiten P.G.M. Systemic effects of dietary n-3 PUFA supplementation accompany changes of CNS parameters in cerebral hypoperfusion. Ann N Y Acad Sci 977 (2002) 77-86
52. De Wilde M.C., Farkas E., Gerrits M., Kiliaan A., and Luiten P.G.M. The effect of n-3 polyunsaturated fatty acid-rich diets on cognitive and cerebrovascular parameters in chronic cerebral hypoperfusion. Brain Res 947 (2002) 166-173
53. 2 vasoreactivity: association with endothelial dysfunction. Am J Physiol Heart Circ Physiol 291 4 (2006) H1856-H1861
54. Böger R.H., Bode-Böger S.M., Szuba A., et al. Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia. Circulation 98 18 (1998) 1842-1847
55. Fisher N.D., Sorond F.A., and Hollenberg N.K. Cocoa flavanols and brain perfusion. J Cardiovasc Pharmacol 47 (2006) S210-S214
56. Raimondi L., Lodovici M., Visioli F., et al. n-3 PUFA supplementation decreases asymmetric dimethyl arginine and arachidonate accumulation in aging spontaneously hypertensive rats. Eur J Nutr 44 (2005) 327-333